<SEC-DOCUMENT>0001493152-20-006965.txt : 20200423
<SEC-HEADER>0001493152-20-006965.hdr.sgml : 20200423
<ACCEPTANCE-DATETIME>20200423084510
ACCESSION NUMBER:		0001493152-20-006965
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		3
CONFORMED PERIOD OF REPORT:	20200423
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20200423
DATE AS OF CHANGE:		20200423

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Celsion CORP
		CENTRAL INDEX KEY:			0000749647
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				521256615
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-15911
		FILM NUMBER:		20809265

	BUSINESS ADDRESS:	
		STREET 1:		997 LENOX DRIVE
		STREET 2:		SUITE 100
		CITY:			LAWRENCEVILLE
		STATE:			NJ
		ZIP:			08648
		BUSINESS PHONE:		(609) 896-9100

	MAIL ADDRESS:	
		STREET 1:		997 LENOX DRIVE
		STREET 2:		SUITE 100
		CITY:			LAWRENCEVILLE
		STATE:			NJ
		ZIP:			08648

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CELSION CORP
		DATE OF NAME CHANGE:	19980515

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CHEUNG LABORATORIES INC
		DATE OF NAME CHANGE:	19920703
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>form8-k.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B></B></FONT></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0; margin-bottom: 0; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 4pt solid; border-bottom: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 18pt"><B>UNITED
STATES</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 18pt"><B>SECURITIES
AND EXCHANGE COMMISSION</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 12pt"><B>WASHINGTON,
DC 20549</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Rule-Page --><DIV STYLE="margin: 0 auto; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 18pt"><B>FORM
8-K</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Rule-Page --><DIV STYLE="margin: 0 auto; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>CURRENT
REPORT</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Pursuant
to Section 13 or 15(d) of the</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Securities
Exchange Act of 1934</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Date
of report (Date of earliest event reported): April 23, 2020 (April 20, 2020)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Rule-Page --><DIV STYLE="margin: 0 auto; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 18pt"><B>Celsion
Corporation</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(Exact
Name of Registrant as Specified in Charter)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin: 0 auto; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 32%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Delaware</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 32%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>001-15911
    </B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 32%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>52-1256615</B></FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(State
        or Other Jurisdiction</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">of
        Incorporation)</FONT></P></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Commission</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">File
        Number)</FONT></P></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(I.R.S.
        Employer</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Identification
        No.)</FONT></P></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>997
Lenox Drive, Suite 100, Lawrenceville, NJ 08648</B></FONT></P>

<!-- Field: Rule-Page --><DIV STYLE="margin: 0 auto; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Address
of Principal Executive Offices, and Zip Code)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(609)
896-9100</B></FONT></P>

<!-- Field: Rule-Page --><DIV STYLE="margin: 0 auto; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Registrant&rsquo;s
Telephone Number, Including Area Code</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>N/A</B></FONT></P>

<!-- Field: Rule-Page --><DIV STYLE="margin: 0 auto; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Former
Name or Former Address, if Changed Since Last Report)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant
under any of the following provisions (<I>see</I> General Instruction A.2. below):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&nbsp;&nbsp;]</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Written
    communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&nbsp;&nbsp;]</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Soliciting
    material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&nbsp;&nbsp;]</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pre-commencement
    communication pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&nbsp;&nbsp;]</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pre-commencement
    communication pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Securities
registered pursuant to Section 12(b) of the Act:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 37%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title
    of each class</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 18%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Trading
    Symbol(s)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 41%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name
    of each exchange on which registered</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Common
    stock, par value $0.01 per share </FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">CLSN</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Nasdaq
    Capital Market</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR
&sect;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR &sect;240.12b-2 of this chapter).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Emerging
growth company [&nbsp;&nbsp;]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for
complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. [&nbsp;&nbsp;]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B></B></FONT></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0; margin-bottom: 0; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid; border-bottom: Black 4pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Item
1.01. Entry into Material Definitive Agreement</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
April 21, 2020, Celsion Corporation (the &ldquo;Company&rdquo;) received $632,220 in loan funding from the Paycheck Protection
Program (the &ldquo;PPP&rdquo;), established pursuant to the recently enacted Coronavirus Aid, Relief, and Economic Security Act
(the &ldquo;CARES Act&rdquo;) and administered by the U.S. Small Business Administration (&ldquo;SBA&rdquo;). The unsecured loan
(the &ldquo;PPP Loan&rdquo;) is evidenced by a promissory note of the Company dated April 20, 2020 (the &ldquo;Note&rdquo;) in
the principal amount of $632,220, to Silicon Valley Bank (the &ldquo;Bank&rdquo;), the lender.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
the terms of the Note and the PPP Loan, interest accrues on the outstanding principal at the rate of 1.0% per annum. The term
of the Note is two years, though it may be payable sooner in connection with an event of default under the Note. To the extent
the loan amount is not forgiven under the PPP, the Company is obligated to make equal monthly payments of principal and interest,
beginning seven months from the date of the Note, until the maturity date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
CARES Act and the PPP provide a mechanism for forgiveness of up to the full amount borrowed. Under the PPP, the Company may apply
for and be granted forgiveness for all or part of the PPP Loan. The amount of loan proceeds eligible for forgiveness is based
on a formula that takes into account a number of factors, including the amount of loan proceeds used by the Company during the
eight-week period after the loan origination for certain purposes including payroll costs, interest on certain mortgage obligations,
rent payments on certain leases, and certain qualified utility payments, provided that at least 75% of the loan amount is used
for eligible payroll costs; the employer maintaining or rehiring employees and maintaining salaries at certain levels; and other
factors. Subject to the other requirements and limitations on loan forgiveness, only loan proceeds spent on payroll and other
eligible costs during the covered eight-week period will qualify for forgiveness. <FONT STYLE="background-color: white">The Company
intends to use the entire Loan amount for qualifying expense, though n</FONT>o assurance is provided that the Company will obtain
forgiveness of the PPP Loan in whole or in part.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Note may be prepaid in part or in full, at any time, without penalty. The Note provides for certain customary events of default,
including (i) failing to make a payment when due under the Note, (ii) failure to do anything required by the Note or any other
loan document, (iii) defaults of any other loan with the Bank, (iv) failure to disclose any material fact or make a materially
false or misleading representation to the Bank or SBA, (v) default on any loan or agreement with another creditor, if the Bank
believes the default may materially affect the Company&rsquo;s ability to pay the Note, (vi) failure to pay any taxes when due,
(vii) becoming the subject of a proceeding under any bankruptcy or insolvency law, having a receiver or liquidator appointed for
any part of the Company&rsquo;s business or property, or making an assignment for the benefit of creditors, (viii) having any
adverse change in financial condition or business operation that the Bank believes may materially affect the Company&rsquo;s ability
to pay the Note, (ix) if the Company reorganizes, merges, consolidates, or otherwise changes ownership or business structure without
the Bank&rsquo;s prior written consent, or (x) becoming the subject of a civil or criminal action that the Bank believes may materially
affect the Company&rsquo;s ability to pay the Note. Upon the occurrence of an event of default, the Bank has customary remedies
and may, among other things, require immediate payment of all amounts owed under the Note, collect all amounts owing from the
Company, and file suit and obtain judgment against the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
foregoing description of the Note is qualified in its entirety by reference to the full text of the Note, a copy of which will
be filed as an Exhibit to the Company&rsquo;s annual Report on Form 10-Q for the three months ending June 30, 2020.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Item
2.03. Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
information disclosed in Item 1.01 above is incorporated herein by reference.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Item
8.01. Other Events</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
April 23, 2020, the Company issued a press release regarding the foregoing matters, a copy of which is attached hereto as Exhibit
99.1 and incorporated herein by reference.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Item 9.01</B></FONT> <FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Exhibits.</B></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(d)
Exhibits</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.75in"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit</B></FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Number</B></FONT></P></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Description</B></FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">99.1</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><A HREF="ex99-1.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Press Release dated April 23, 2020</FONT></A></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>


<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SIGNATURES</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf
by the undersigned hereunto duly authorized.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>CELSION
    CORPORATION</B></FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 4%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 46%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:
    April 23, 2020</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    Jeffrey W. Church</I></FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jeffrey
    W. Church</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Executive
    Vice President</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">and
    Chief Financial Officer</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 4; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>ex99-1.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
99.1</B></FONT></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; color: Red; margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><IMG SRC="ex99-1_001.jpg" ALT=""></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; color: Red; margin-top: 0; margin-bottom: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Celsion
Receives $2.5 Million in Non-Dilutive Funding from the Sale of its New Jersey State Net Operating Losses and Grant Funding Under
the Paycheck Protection Program</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Added
Capital Strengthens Balance Sheet, Assures Cash Through Major Phase III OPTIMA Study Data Readout Events</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Sale
of an Additional $2.0 Million of NOL&rsquo;s Expected in the 4<SUP>th</SUP> Quarter of 2020</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>LAWRENCEVILLE,
N.J., (April 23, 2020)</B> &ndash; Celsion Corporation (NASDAQ: CLSN), an oncology drug development company, today announced it
has received $1.82 million of net cash proceeds from the sale of approximately $1.9 million of its unused New Jersey net operating
losses (NOLs) and $632,220 in funding under the Paycheck Protection Program (PPP), <FONT STYLE="background-color: white">the federal
government&rsquo;s main initiative to help small businesses disrupted by the COVID-19 pandemic.</FONT> The NOL sales cover the
tax years 2017 and 2018 and are administered through the New Jersey Economic Development Authority&rsquo;s (NJEDA) Technology
Business Tax Certificate Transfer (NOL) Program. With this new $2.5 million funding, coupled with the $4.4 million in net proceeds
from the recent registered direct equity offer completed on March 3, 2020, the Company has strengthened its balance sheet at a
time of stock market uncertainty. An additional sale of $2.0 million of unused New Jersey NOLs anticipated in the second half
of 2020 will further increase Celsion&rsquo;s cash reserves on a non-dilutive basis. In addition, the Company has initiated several
cost containment measures to ensure that it has sufficient cash to fund operations and clinical development programs through the
second quarter of 2021 and all major Phase III OPTIMA Study readouts.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
competitive New Jersey NOL Program enables approved companies to sell their unused New Jersey NOLs and R&amp;D tax credits to
unaffiliated, profit-generating corporate taxpayers in the state of New Jersey, up to a maximum lifetime benefit of $15 million
per company. This allows technology and biotechnology companies with NOLs to turn their tax losses and credits into cash proceeds
to fund more research and development (R&amp;D), expand its workforce or cover other allowable expenditures.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">Loans
made under the Paycheck Protection Program have two-year terms and charge 1% interest. If borrowers follow guidelines and use
at least 75% of the money for eligible payroll costs, some or all of the loan may be forgiven. Celsion anticipates meeting these
guidelines for full forgiveness of its PPP loan.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;This
innovative economic development program offered by the NJEDA reinforces our belief in the State of New Jersey&rsquo;s commitment
to the biotechnology industry and to the development of new life-saving therapies. We will participate in this program again in
2020 to secure the remaining $2 million available to us under the maximum lifetime benefit of $15 million per company,&rdquo;
said Michael H. Tardugno, Celsion Corporation&rsquo;s chairman, president and chief executive officer. &ldquo;The $2.5 million
in proceeds from the NOL sale and the PPP loan coupled with the $4.4 million in net proceeds from the recently completed registered
direct equity offering strengthen our cash position and extend Celsion&rsquo;s cash runway through the second quarter of 2021.
We are positioned to advance our development programs well beyond several expected key value inflection points, including the
second interim efficacy analysis of the Phase III OPTIMA Study for ThermoDox<SUP>&reg;</SUP> and, if needed, the final efficacy
readout in the first quarter of 2021. We appreciate the support and commitment of the NJEDA in facilitating our continued innovation
and applaud their efforts to foster continued investment and growth for businesses in New Jersey.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;Over
the past two years, Celsion has sought investor friendly ways to finance our clinical development programs in some of the world&rsquo;s
most devastating cancers. Balancing the high cost of research and drug development without losing focus on our shareholders is
not only reflected in our sale of unused New Jersey NOLs and successful application for Federal grant monies, it is further demonstrated
by our judicious use of venture debt on terms that give us an operating runway into mid-2021,&rdquo; said Jeffrey W. Church, Celsion
Corporation&rsquo;s executive vice president and CFO. &ldquo;With the continued support of our shareholders, we look forward to
a promising 2020.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
more details on this funding for this year&rsquo;s NOL program, please visit <U>www.njeda.com</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>About
Celsion Corporation</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Celsion
is a fully integrated oncology company focused on developing a portfolio of innovative cancer treatments, including directed chemotherapies,
immunotherapies and RNA- or DNA-based therapies. The Company&rsquo;s lead program is ThermoDox<SUP>&reg;</SUP>, a proprietary
heat-activated liposomal encapsulation of doxorubicin, currently in Phase III development for the treatment of primary liver cancer.&nbsp;
The pipeline also includes GEN-1, a DNA-based immunotherapy for the localized treatment of ovarian cancer.&nbsp; Celsion has two
platform technologies for the development of novel nucleic acid-based immunotherapies and other anti-cancer DNA or RNA therapies.
For more information on Celsion, please visit <U>www.celsion.com</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Celsion
wishes to inform readers that forward-looking statements in this release are made pursuant to the &ldquo;safe harbor&rdquo; provisions
of the Private Securities Litigation Reform Act of 1995.&nbsp; Readers are cautioned that such forward-looking statements involve
risks and uncertainties including, without limitation, unforeseen changes in the course of research and development activities
and in clinical trials; the uncertainties of and difficulties in analyzing interim clinical data; the significant expense, time,
and risk of failure of conducting clinical trials; the need for Celsion to evaluate its future development plans; possible acquisitions
or licenses of other technologies, assets or businesses; possible actions by customers, suppliers, competitors, regulatory authorities;
and other risks detailed from time to time in Celsion&rsquo;s periodic reports and prospectuses filed with the Securities and
Exchange Commission.&nbsp; Celsion assumes no obligation to update or supplement forward-looking statements that become untrue
because of subsequent events, new information or otherwise.</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Celsion
Investor Contact</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jeffrey
W. Church</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Executive
Vice President and CFO</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">609-482-2455</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>jchurch@celsion.com</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Or</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>LHA
Investor Relations</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Kim
Sutton Golodetz</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">212-838-3777</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>kgolodetz@lhai.com</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">#
# #</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 2; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>ex99-1_001.jpg
<TEXT>
begin 644 ex99-1_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1"  W (@# 2(  A$! Q$!_\0
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M"[M+J&*YMKJVECGMKFWN(UF@N+>>)FBG@GB=)89HV:.6-E=&96!/XD_MG?\
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MUGPL?&VNV&FWEE+XV\6^+M;F\/Z=K>I-X=\)^')8+'4/LJ?M*_\ !.;_ (*
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MB76]6\ ZUX:TC4/&?BF[CN)L7&HW\ FF2"2#2=.6*SLK<VME!$?SS_X)B_\
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MTMH_.]W='\^/PC_9V_X.3O\ @G]X?NO@-\ [[X+_ +3/P9TRZU.W\!Z[XO\
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9T7:/_I*"BBBL1A1110 4444 %%%% '__V0$!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
